跳至主要内容
临床试验/JPRN-UMIN000021029
JPRN-UMIN000021029招募中3 期

A randomized phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer (JCOG1408, J-SBRT trial) - A randomized phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer (JCOG1408, J-SBRT trial)

Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 750 人开始时间: 2016年2月15日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Synchronous or metachronous (within 5 years) malignancies. 2. Active infection requiring systemic therapy. 3. Body temperature of 38 or more degrees Celsius. 4. Women during pregnancy or possible pregnancy, within 28 days after delivery, or during breast-feeding. 5. Severe mental disease. 6. Receiving continuous systemic steroid or immune-suppressive medication. 7. Idiopathic pulmonary fibrosis on CT. 8. Severe cough requiring narcortic drugs.

研究者

发起方
Japan Clinical Oncology Group (JCOG)

相似试验

A randomized phase III trial of comparing two... | 临床试验